Quick Answer
PALISADE BIO, INC. reported Earnings Per Share Diluted of $0.30 (loss) per share for the year ending 2025.
- PALISADE BIO, INC. showed an increase of +97.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), PALISADE BIO, INC.'s Earnings Per Share Diluted has grown by 91.9%.
- Historical annual values: Fiscal year 2025: $0.30 (loss) per share | Fiscal year 2024: $10.19 (loss) per share | Fiscal year 2023: $27.01 (loss) per share | Fiscal year 2022: $16.53 (loss) per share | Fiscal year 2021: $169.74 (loss) per share | Fiscal year 2020: $3.72 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: